Our nation is dealing with the COVID-19 pandemic which has forced doctors, like OB-GYNs, to find ways to continue delivering care out of their clinics and into the patient’s home. The article “Prenatal Care May Look Very Different After Coronavirus” published by The New York Times discusses this
“shift from in-person visits to telehealth appointments” and how it “could be here to stay”. Healthcare providers have begun to discover the value virtual care can bring far beyond this pandemic.
While COVID-19 has recently made telehealth a “household name” and accelerated its adoption, The New York Times article does not identify those who have seen it’s great potential for years. Those doctors, forward thinking leaders, and innovators who have successfully implemented telehealth in their hospitals and medical practices.
Jollitot has been at the forefront of helping to innovate prenatal care. We believe that pregnancies can be supported by using technology, such as mobile apps and remote monitoring medical devices, to both reduce the number of in-office visits and increase the standard of care. The use of these tools will allow providers to more quickly identify patient risk outside of their clinic.
There are many research studies that prove the efficacy of this program and the great impact our technology can improve patient satisfaction, increase the quality of care, and reduce overall healthcare cost.
One of the main concerns is the loss a patient and provider connection while using telehealth. There have been surveys of patients to measure and evaluate their satisfaction rate. The study concluded that despite the provider seeing the patient less often in a reduced in-office visit schedule, pregnant mothers reported a high satisfaction rate. This study busted one of the myths of telehealth that less visits caused a weak patient and provider connection.